Found: 79
Select item for more details and to access through your institution.
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 2963, doi. 10.1007/s00432-022-04193-w
- By:
- Publication type:
- Article
Risk Factors for Pneumonia and Death in Adult Patients With Seasonal Influenza and Establishment of Prediction Scores: A Population-Based Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 3, p. 1, doi. 10.1093/ofid/ofab068
- By:
- Publication type:
- Article
Association of the lung immune prognostic index with the survival of patients with idiopathic interstitial pneumonias.
- Published in:
- Respirology, 2024, v. 29, n. 2, p. 136, doi. 10.1111/resp.14621
- By:
- Publication type:
- Article
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.
- Published in:
- Respirology, 2023, v. 28, n. 8, p. 775, doi. 10.1111/resp.14523
- By:
- Publication type:
- Article
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis‐associated ILD: A randomized, open‐label trial.
- Published in:
- Respirology, 2021, v. 26, n. 4, p. 370, doi. 10.1111/resp.13978
- By:
- Publication type:
- Article
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
- Published in:
- Respirology, 2021, v. 26, n. 2, p. 171, doi. 10.1111/resp.13943
- By:
- Publication type:
- Article
Clinical significance of serum S100 calcium‐binding protein A4 in idiopathic pulmonary fibrosis.
- Published in:
- Respirology, 2020, v. 25, n. 7, p. 743, doi. 10.1111/resp.13707
- By:
- Publication type:
- Article
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis.
- Published in:
- Respirology, 2019, v. 24, n. 8, p. 792, doi. 10.1111/resp.13506
- By:
- Publication type:
- Article
Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13333-8
- By:
- Publication type:
- Article
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98161-y
- By:
- Publication type:
- Article
Clinical significance of soluble CD163 in polymyositis-related or dermatomyositisrelated interstitial lung disease.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-016-1214-8
- By:
- Publication type:
- Article
Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 8996, doi. 10.3390/ijms23168996
- By:
- Publication type:
- Article
The providing multidisciplinary ILD diagnoses (PROMISE) study – study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03232-1
- By:
- Publication type:
- Article
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03284-3
- By:
- Publication type:
- Article
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 7, p. 1498, doi. 10.3390/jcm10071498
- By:
- Publication type:
- Article
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 1867, doi. 10.2147/COPD.S214610
- By:
- Publication type:
- Article
Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 1333, doi. 10.2147/COPD.S207267
- By:
- Publication type:
- Article
Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 210, doi. 10.1007/s10637-020-00988-1
- By:
- Publication type:
- Article
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 531, doi. 10.1007/s10637-019-00747-x
- By:
- Publication type:
- Article
Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD.
- Published in:
- Scientific Reports, 2017, p. 41709, doi. 10.1038/srep41709
- By:
- Publication type:
- Article
Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120313
- By:
- Publication type:
- Article
Prognostic Factors for Myositis-Associated Interstitial Lung Disease.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0098824
- By:
- Publication type:
- Article
"Bull's-eye" Sign and Its Longitudinal Change on High-Resolution Computed Tomography in Pulmonary Sarcoidosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 1, p. e1, doi. 10.1164/rccm.202307-1226IM
- By:
- Publication type:
- Article
Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cluster analysis-based clinical phenotypes of idiopathic interstitial pneumonias: associations with acute exacerbation and overall survival.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2717, doi. 10.1007/s00262-023-03453-z
- By:
- Publication type:
- Article
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 203, doi. 10.1007/s00262-021-02979-4
- By:
- Publication type:
- Article
The potential of leg-foot chest compression as an alternative to conventional hands-on compression during cardiopulmonary resuscitation.
- Published in:
- Hong Kong Journal of Emergency Medicine, 2019, v. 26, n. 2, p. 106, doi. 10.1177/1024907918790068
- By:
- Publication type:
- Article
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.
- Published in:
- Lung, 2016, v. 194, n. 2, p. 235, doi. 10.1007/s00408-016-9851-x
- By:
- Publication type:
- Article
Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial.
- Published in:
- Journal of Asthma & Allergy, 2019, v. 12, p. 253, doi. 10.2147/JAA.S223093
- By:
- Publication type:
- Article
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.
- Published in:
- Clinical Respiratory Journal, 2018, v. 12, n. 8, p. 2378, doi. 10.1111/crj.12918
- By:
- Publication type:
- Article
CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2023, v. 68, n. 2, p. 201, doi. 10.1165/rcmb.2022-0109OC
- By:
- Publication type:
- Article
CD109 on dendritic cells regulates airway hyperreactivity and eosinophilic airway inflammation.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2023, v. 68, n. 2, p. E1, doi. 10.1165/rcmb.2022-0109oc
- By:
- Publication type:
- Article
Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46990-3
- By:
- Publication type:
- Article
Pneumothorax in connective tissue disease-associated interstitial lung disease.
- Published in:
- PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0235624
- By:
- Publication type:
- Article
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620953783
- By:
- Publication type:
- Article
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620935774
- By:
- Publication type:
- Article
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620953783
- By:
- Publication type:
- Article
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620935774
- By:
- Publication type:
- Article
Pulse oximetric saturation to fraction of inspired oxygen (SpO<sub>2</sub>/FIO<sub>2</sub>) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620906327
- By:
- Publication type:
- Article